B-Cure Laser

Low-level Laser Therapy Device for Home Use

Health Tech & Life Sciences
Active
Public Tirat Carmel Founded 2007
Total raised
$25.5M
Stage
Public
Founded
2007
Headcount
29
HQ
Tirat Carmel
Sector
Health Tech & Life Sciences

About

B-Cure Laser offers a line of products providing clinical low-level laser power in a light, portable, rechargeable, and user-friendly medical device. The device is designed for the rapid, noninvasive, and efficient treatment of pain, orthopedic conditions, wounds, burns and skin problems, inflammation, and sports injuries.

The company's products utilize class-one lasers and are sold over the counter. B-Cure Laser products are marketed and distributed by Good Energies Ltd.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When did B-Cure Laser become a public company?
B-Cure Laser became a public company in May 2021, listing on the TASE.
What was the total amount of funding raised by B-Cure Laser?
B-Cure Laser has raised a total of $25.5 million in funding. For a full financing history, please refer to startupim.
What is the primary product offered by B-Cure Laser?
B-Cure Laser offers a line of products providing clinical low-level laser power in a light, portable, rechargeable, and user-friendly medical device for home use.
What is the employee count for B-Cure Laser?
B-Cure Laser has an employee count ranging from 11 to 50, with an exact count of 29 employees.
What was a significant operational development for B-Cure Laser in December 2022?
In December 2022, B-Cure Laser terminated its CEO after six months, citing a 'crisis of confidence'.
What financial forecast did B-Cure Laser make in June 2022?
In June 2022, B-Cure Laser projected a sharp decline in revenues and an operating loss of 17 million ILS.
What regulatory issue did B-Cure Laser face in February 2024?
In February 2024, the Securities Authority initiated an investigation into Erika B-Cure Laser regarding European approvals.
What was the market performance of B-Cure Laser's stock in March 2024?
In March 2024, B-Cure Laser's stock collapsed by 96%.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
SensingLaser
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsConsumersDemographics & FamilySeniorsRecreational & LifestyleFitness & Sports
Business model
B2CB2B

Highlights

1 Patents

Tags

skinnon-invasiveorthopedicstherapeuticslasershome-careburnsmedical-devicesskin-carepain-reliefathletesseniorsclinicshealthcare-providerssportsdentalanti-inflammatoryinfectionpatientshospitalsoptronicsmedical-technologiestreatments